Avalo Therapeutics (C6K0.F) Q1 2025 Earnings

20MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-130.63
-87.14
-43.65
-0.16

Details

Expected EPS
-0.15504310965
Actual EPS
-2.1184149999999997
Surprise EPS
-1.96
Surprise Percent
+1,266.34%

Description

Avalo Therapeutics (C6K0.F) has reported earnings of -2.1184149999999997 per share for Q1 2025.

0 Comments

Share your thoughts